PFA

Revenue growth above 20%Net loss reportedEBITDA margin expansionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.1%Reaction day

₹98.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%+7.6% vs market

Medical Equipment & Supplies peers, median of 13sector-1.6%+7.7% vs sector

On the reaction day the stock moved 7.6 pts more than Nifty Microcap 250 and 7.7 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.1-1.5+7.6-1.6+7.7

Next day

+0.0-2.2+2.2-1.3+1.3

+2.0-1.2+3.3-0.7+2.7

+2.0-0.9+3.0-0.5+2.6

—-2.3—-2.6—

-3.3-2.5-0.8-2.6-0.6

-10.2-3.6-6.6-3.7-6.5

15d

—-10.4—-9.9—

+9.2-11.3+20.5-9.4+18.6

-2.2-3.6+1.3-5.4+3.1

-0.5+3.9-4.4-4.2+3.7

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Centenial Surgical Suture Ltd reported strong Q3 FY26 results with revenue from operations of ₹1,486.42 lakhs, up 21.9% from ₹1,219.88 lakhs in Q3 FY25. The company swung to a profit of ₹14.70 lakhs in Q3 FY26 from a loss of ₹84.77 lakhs in the same quarter last year, with EPS improving to ₹0.40 from (₹2.30). For nine months ended December 31, 2025, revenue grew modestly to ₹4,125.53 lakhs versus ₹4,020.85 lakhs in the prior year period, with a profit of ₹10.88 lakhs compared to a loss of ₹28.02 lakhs. EBITDA margin expanded meaningfully to around 10.6% in Q3 FY26 from about 6.2% in Q3 FY25, driven by better operating leverage and lower finance costs. The statutory auditor issued an unqualified limited review report with no qualifications or emphasis of matter.

Likely market impact

A sharp year-on-year turnaround to profitability, strong revenue growth, and improving margins are positive signals for shareholders, though the absolute profit remains small and dependent on continued revenue momentum.